ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million
21 Oct, 2021
– GeneQuine is a Hamburg, Germany-based biotech company focused on the development of gene therapy for musculoskeletal disorders.
– The company raised a total of €9.05m in Series A and non-dilutive funding.
– The round was led by Pacira BioSciences, Inc. (Nasdaq: PCRX), with participation from High-Tech Gründerfonds, Noshaq SA, and Samum Vermögensverwaltungs GmbH.